“Chances are you can't get your hands on Bausch + Lomb Inc.'s new Ultra monthly contact lens,” writes the Rochester Democrat and Chronicle. “The eye-care company has only one manufacturing line producing them, at its North Goodman Street plant. The lenses are available only in the United States, and not yet nationwide. And demand so far is outstripping supply. ‘We're selling every lens we can make,’ said J. Michael Pearson, CEO of B+L parent company Valeant Pharmaceutics International Inc. But all of that is changing. B+L and parent company Valeant Pharmaceuticals International Inc. on Monday cut the ribbon on what will become a major manufacturing addition to the company's Rochester plant. Along with the two Ultra manufacturing lines being installed there,…B+L will put in a third and fourth.” Read more.